Serum magnesium aberrations in furosemide (frusemide) treated patients with congestive heart failure: pathophysiological correlates and prognostic evaluation

N Cohen; D Almoznino-Sarafian; R Zaidenstein; I Alon; O Gorelik; M Shteinshnaider; S Chachashvily; Z Averbukh; A Golik; Z Chen-Levy; D Modai

doi:10.1136/heart.89.4.411

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BCS

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Browse by collection

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via BCS

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Cardiovascular medicine

Serum magnesium aberrations in furosemide (frusemide) treated patients with congestive heart failure: pathophysiological correlates and prognostic evaluation

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Cohen N, Almoznino-Sarafian D, Zaidenstein R, et al

Serum magnesium aberrations in furosemide (frusemide) treated patients with congestive heart failure: pathophysiological correlates and prognostic evaluation

Heart 2003;89:411-416.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password